Share this:
Devices snaked into the brain artery of a patient experiencing a stroke should primarily be used within a clinical trial setting. Vascular neurologists at Mayo Clinic in Florida say the devices, known collectively as endovascular stroke therapy, should predominantly be limited to use within clinical trials.
A growing number of physicians who treat stroke are currently using these tools, so Kevin Barrett, M.D., co-medical director of Mayo Clinic’s Primary Stroke Center in Florida, acknowledges the recommendation to limit use will be controversial. The research is presented in Mayo Clinic Proceedings.
Read entire news release: Stroke Trials
Journalists: Sound bites with Dr. Barrett are available in the downloads
Share this:
Related articles
MANKATO, Minn. — You've thought about it for years. You've dreamed of crossing the finish line. It's on your bucket list, or maybe it's become ...
Fourth-year students at Mayo Clinic Alix School of Medicine in Arizona, Florida and Minnesota learned where they will continue their residency training on March 17. Also, Mayo Clinic ...
Many people are flocking to the Gulf Coast for spring break. However, toxic red tide algal blooms have put beachgoers and residents on alert. In the ...